Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling
3 other identifiers
interventional
78
1 country
1
Brief Summary
The purpose of this research study is to understand the impact of an educational video or pamphlet on the patient experience in a hereditary cancer genetic counseling program. In order to make this assessment, it is necessary to perform qualitative and quantitative research among patients in a hereditary cancer genetic counseling clinic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 25, 2021
CompletedFirst Submitted
Initial submission to the registry
October 25, 2021
CompletedFirst Posted
Study publicly available on registry
November 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2023
CompletedAugust 9, 2024
August 1, 2024
2.1 years
October 25, 2021
August 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient impact with educational information prior to genetic counseling
Impact will be defined as the number of questions asked by patient during the counseling.
36 months
Patient impact without any educational information prior to genetic counseling
Impact will be defined as the number of questions asked by patient during the counseling.
36 months
Study Arms (3)
pre-educated with educational video
EXPERIMENTALParticipants will receive a message to view educational videos prior to their genetic counseling appointment if they are assigned to a pre-educated arm. The video will be shared with patients via MyHealth in the "education" tab in advance of the genetic counseling session
pre-educated with pamphlet
EXPERIMENTALParticipants will receive a message to view a pamphlet prior to their genetic counseling appointment if they are assigned to a pre-educated arm. The pamphlet will be sent to patients who cannot access the video via regular mail in advance of the genetic counseling session
educated during the session
OTHERParticipants will receive traditional genetic counseling. . After the genetic counseling session, they will fill out a validated survey called the Multi-dimensional Measure of Informed Choice (MMIC) that assesses attitudes, knowledge, and uptake of genetic testing
Interventions
The primary intervention in this study is watching the video or reading the pamphlet in advance of the genetic counseling session, which overview the same information that we currently provide in-person/via telehealth during the genetic counseling session.
Patients will receive traditional genetic counseling
Eligibility Criteria
You may qualify if:
- Preferred language for receiving medical information is Spanish
- Has a personal or family history of cancer
- If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet
- Personal or family history of breast cancer
- English is preferred language
- If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet
- Personal or family history of prostate cancer
- English is preferred language
- If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet
- Personal or family history of any type of cancer
- Referred based on a variant identified during tumor genomic analysis
- English is preferred language
- If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet
- Personal or family history of gastrointestinal or gynecologic cancer
- Screened positive for Lynch Syndrome based on IHC or MMR testing
- +5 more criteria
You may not qualify if:
- Individuals who are minors
- Individuals who are decisionally impaired
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University
Palo Alto, California, 94305, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James Ford, MD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
October 25, 2021
First Posted
November 24, 2021
Study Start
May 25, 2021
Primary Completion
June 28, 2023
Study Completion
June 28, 2023
Last Updated
August 9, 2024
Record last verified: 2024-08